Immunotherapy of tumors with neuroimmune ligand capsaicin

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 3260-3264

  Beltran, Jacqueline ^a   Ghosh, Amiya K ^a   Basu, Sreyashi ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

ADOLESCENT; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; FIBROSARCOMA; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; PEPPER; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33847370000     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.5.3260     Document Type: Article

References (20)

1. Szallasi, A., and P. M. Blumberg. 1999. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51: 159-212.
2. Govindarajan, V. S., and M. N. Sathyanarayana. 1991. Capsicum: production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences. Crit. Rev. Food Sci. Nutr. 29: 435-474.
3. Surh, Y.-J., and S. Sup Lee. 1995. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 56: 1845-1855.
4. Surh, Y.-J., and S. S. Lee. 1996. Capsaicin in hot chili pepper: carcinogen, cocarcinogen or anticarcinogen? Food Chem. Toxicol. 34: 313-316.
5. Holzer, P. 1991. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43: 143-201.
6. Caterina, M. J., M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
7. Caterina, M. J., A. Leffler, A. B. Malmberg, W. J. Martin, J. Trafton, K. R. Petersen-Zeitz, M. Koltzenburg, A. I. Basbaum, and D. Julius. 2000. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
8. Montell, C. 2001. Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci. STKE 2001: RE1.
9. Yu, R., J. W. Park, T. Kurata, and K. L. Erickson. 1998. Modulation of select immune responses by dietary capsaicin. Int. J. Vitam. Nutr. Res. 68: 114-119.
10. Kradin, R., J. MacLean, S. Duckett, E. E. Schneeberger, C. Waeber, and C. Pinto. 1997. Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen. Am. J. Pathol. 150: 1735-1743.
11. Basu, S., and P. Srivastava. 2005. Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc. Natl. Acad. Sci. USA 102: 5120-5125.
12. Srivastava, P. K., A. B. DeLeo, and L. J. Old. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83: 3407-3411.
13. Huang, A. Y., P. H. Gulden, A. S. Woods, M. C. Thomas, C. D. Tong, W. Wang, V. H. Engelhard, G. Pasternack, R. Cotter, D. Hunt, et al. 1996. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA 93: 9730-9735.
14. Lugade, A. A., J. P. Moran, S. A. Gerber, R. C. Rose, J. G. Frelinger, and E. M. Lord. 2005. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J. Immunol. 174: 7516-7523.
15. Casares, N., M. O. Pequignot, A. Tesniere, F. Ghiringhelli, S. Roux, N. Chaput, E. Schmitt, A. Hamai, S. Hervas-Stubbs, M. Obeid, et al. 2005. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202: 1691-1701.
16. Nowak, A. K., R. A. Lake, A. L. Marzo, B. Scott, W. R. Heath, E. J. Collins, J. A. Frelinger, and B. W. Robinson. 2003. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J. Immunol. 170: 4905-4913.
17. Buttiglieri, S., A. Galetto, S. Forno, M. De Andrea, and L. Matera. 2003. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. Int. J. Cancer 106: 516-520.
18. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
19. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
20. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12: 1539-1546.